Which of the following is not applicable to Cryoprecipitate?

Prepare for the CAMLPR Specimen Collection Competency Test. Practice with diverse question sets including multiple-choice and flashcards. Each question includes hints and explanations to help you become proficient before the exam.

Cryoprecipitate is a plasma-derived product created by thawing fresh frozen plasma at cold temperatures to make a small, protein-rich portion that contains fibrinogen and other clotting factors. It is stored frozen until it’s needed, then thawed for transfusion and used promptly. This handling relies on cold processing and careful timing because once thawed, the product is time‑sensitive, especially if kept in an open (non-closed) system.

Pooling is not done at room temperature for cryoprecipitate; if multiple units are combined, it’s done under controlled, sterile conditions rather than simply blending at ambient conditions. That’s why the statement about being pooled at room temperature isn’t applicable to cryoprecipitate. In contrast, using cryoprecipitate for fibrinogen deficiency is standard, and after thawing in an open system it must be used within a short window (around 4–5 hours, depending on protocol). Store frozen until use, and it’s thawed only as needed, then transfused promptly.